Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Live-Dead Cell Staining Kit: Precision Calcein-AM PI Assays
2026-07-09
The Live-Dead Cell Staining Kit leverages Calcein-AM and Propidium Iodide dual staining to enable rapid, quantitative viability analysis across advanced workflows. Its robust performance in fluorescence microscopy and flow cytometry sets a new standard for reproducibility, especially in cytotoxicity testing and biomaterial biocompatibility studies.
-
TRPV1 and TRPA1 Drive TSLP Release in Nasal Epithelial Cells
2026-07-08
This study demonstrates that TRPV1 and TRPA1 channels are functionally expressed in nasal epithelial cells and that their activation induces TSLP production via a Ca2+/NFAT-dependent pathway. These findings clarify the molecular link between sensory ion channel signaling and airway inflammation, informing new research strategies for nonallergic rhinitis.
-
PD 173074: Precision FGFR1/VEGFR2 Inhibition in Cancer Resea
2026-07-08
PD 173074 empowers researchers with nanomolar-selective FGFR1 and VEGFR2 inhibition, enabling reproducible insights into angiogenesis and multidrug resistance. This article delivers actionable protocols, advanced applications, and troubleshooting strategies—bridging bench workflows to robust translational outcomes.
-
Ceftolozane/Tazobactam: Advancing Antipseudomonal Cephalospo
2026-07-07
The referenced study outlines the mechanistic and clinical rationale for the ceftolozane/tazobactam combination, highlighting its superior activity against Pseudomonas aeruginosa and ESBL-producing Enterobacteriaceae. Its unique pharmacodynamic properties and robust efficacy in resistant infections mark a substantial advancement in cephalosporin-based therapy.
-
Treponema pallidum Triggers Mitochondrial Apoptosis in Hepat
2026-07-07
This study demonstrates that Treponema pallidum induces intrinsic apoptosis in hepatocytes via mitochondrial ROS accumulation and cardiolipin peroxidation. The findings clarify a mitochondria-centered mechanism of liver injury in syphilis, with implications for cell death mechanism research and mitochondrial dysfunction assays.
-
IR-1061: Near Infrared Fluorescent Dye for Deep Tissue Imagi
2026-07-06
IR-1061 stands at the forefront of near infrared fluorescent dye technology, driving high-sensitivity in vivo imaging with deep tissue penetration and minimal background. This guide translates the latest research into hands-on protocols and troubleshooting insights, empowering biomedical researchers to maximize clarity and reproducibility in optical and molecular imaging workflows.
-
Silybin A in Silymarin: Precision Workflows for Hepatoprotec
2026-07-06
Silybin A, the principal bioactive in silymarin, empowers high-fidelity workflows for liver disease, metabolic, and oxidative stress research. This article guides researchers through optimized protocols, advanced use-cases, and troubleshooting strategies, leveraging APExBIO’s rigorously validated Silybin A for maximal reproducibility and translational impact.
-
Innovative ROS Quantification: Leveraging the DCFH-DA Assay
2026-07-05
Explore the science and advanced applications of the Reactive Oxygen Species Assay Kit for precise oxidative stress measurement. This article offers unique technical insights and practical assay guidance for cellular ROS quantification in cancer and cell biology research.
-
Bifendate Inhibits Autophagy and Reduces Lipid Accumulation
2026-07-04
This study reveals that bifendate (DDB), a clinically used hepatoprotective agent, inhibits autophagy at multiple steps and reduces oleic acid-induced lipid droplet accumulation in cultured cells. The findings clarify DDB's mechanisms in modulating lysosomal function and lipid metabolism, opening paths for further research in hepatic disease models.
-
FITC Goat Anti-Rabbit IgG (H+L) Antibody: Precision in Fluor
2026-07-03
The FITC Goat Anti-Rabbit IgG (H+L) Antibody delivers robust, reproducible fluorescence-based detection of rabbit primary antibodies across immunofluorescence, flow cytometry, and immunohistochemistry. Explore protocol enhancements, troubleshooting strategies, and learn how the latest research on intestinal barrier dysfunction leverages this reagent for high-impact experimental clarity.
-
Tamsulosin in Translational Biology: Precision Dosing and Pr
2026-07-03
Explore the advanced pharmacology and translational impact of Tamsulosin, a selective α₁A-adrenergic receptor antagonist, in urological and smooth muscle research. This article reveals how precision dosing and new biomarker data change practical assay design, offering unique guidance for research beyond standard protocols.
-
AP1903: Precision FKBP-Binding Ligand for Conditional Cell A
2026-07-02
AP1903 enables nanomolar-precision control over FKBP fusion proteins, powering apoptosis pathway research and conditional cell ablation with unprecedented specificity. Its compatibility with multiplexed, high-throughput workflows distinguishes it as the gold standard for synthetic biology and functional genomics.
-
Hypoxia-Activated Photomolecular Glues: Advancing Tumor Sele
2026-07-02
This article examines the development and validation of a hypoxia-activated photomolecular glue (BNNC) designed to synergistically degrade Cyclin K and enhance phototherapeutic efficacy in cancer cells. The study's innovation lies in its tumor-specific activation and dual-action mechanism, which together improve antitumor selectivity and therapeutic outcomes with minimized off-target toxicity.
-
Cediranib (AZD2171): Precision Workflows in Cancer Research
2026-07-01
Cediranib (AZD2171) from APExBIO enables exceptionally precise inhibition of VEGFR signaling, powering advanced angiogenesis assays and mechanistic studies in oncology. This guide synthesizes recent innovations and troubleshooting insights to help researchers maximize reproducibility and data quality with Cediranib in in vitro cancer models.
-
DAPT (GSI-IX) in Notch Pathway Research: Protocols & Insight
2026-07-01
DAPT (GSI-IX) empowers researchers to selectively dissect γ-secretase and Notch signaling with high precision, supporting robust experimental workflows in neurodegeneration, cancer, and vascular biology. This article delivers actionable protocols, troubleshooting guidance, and translational research strategies, grounded in recent angiogenesis studies and enhanced by APExBIO’s quality assurance.